Point72 Asset Management’s Neurocrine Biosciences NBIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
|
|||||
|
2024
Q1 | $115M | Sell |
|
|||||
|
2023
Q4 | $183M | Sell |
|
|||||
|
2023
Q3 | $290M | Buy |
|
|||||
|
2023
Q2 | $10.5M | Buy |
|
|||||
|
2022
Q3 | – | Sell |
|
|||||
|
2022
Q2 | $64.9M | Buy |
|
|||||
|
2022
Q1 | $54.2M | Buy |
|
|||||
|
2021
Q4 | $45M | Buy |
|
|||||
|
2021
Q3 | $14.3M | Buy |
|
|||||
|
2021
Q1 | – | Sell |
|
|||||
|
2020
Q4 | $2.17M | Buy |
|
|||||
|
2020
Q2 | – | Sell |
|
|||||
|
2020
Q1 | $1.57M | Sell |
|
|||||
|
2019
Q4 | $6.45M | Buy |
|
|||||
|
2019
Q3 | $2.66M | Sell |
|
|||||
|
2019
Q2 | $95M | Buy |
|
|||||
|
2019
Q1 | $34.2M | Buy |
|
|||||
|
2018
Q4 | – | Sell |
|
|||||
|
2018
Q3 | $7.99M | Sell |
|
|||||
|
2018
Q2 | $88M | Buy |
|
|||||
|
2018
Q1 | $6.22M | Buy |
|
|||||
|
2017
Q4 | – | Sell |
|
|||||
|
2017
Q3 | $16.9M | Sell |
|
|||||
|
2017
Q2 | $27M | Buy |
|
|||||
|
2017
Q1 | $4.33M | Buy |
|
|||||
|
2015
Q3 | – | Sell |
|
|||||
|
2015
Q2 | $1.8M | Sell |
|
|||||
|
2015
Q1 | $9.26M | Buy |
|